Table 4.
Association of pfdhfr triple mutations and different drug intakes among pregnant women.
| Drug intake | Number examined (%) | Number positive (%)* | Triple pfdhfr# | |
|---|---|---|---|---|
| Mutant | Wildtype | |||
| Dihydroartemisinin | 36 (18.0) | 13 (21.0) | 6 (46.2) | 7 (53.8) |
| Chloroquine | 27 (13.5) | 9 (15.0) | 1 (11.1) | 8 (88.9) |
| Pyrimethamine | 17 (8.5) | 6 (10.0) | 4 (66.7) | 2 (33.4) |
| Sulfadoxine- Pyrimethamine | 41 (20.5) | 10 (16.7) | 9 (90.0) | 1 (10.0) |
| None | 79 (39.5) | 26 (36.7) | 18 (81.8) | 4 (18.2) |
*
The difference between groups was not statistically significant
#
The difference between groups was statistically significant (p = 0.007).